Literature DB >> 18670867

Lactose contaminant as steroid degradation enhancer.

Florentine Nieuwmeyer1, Kees van der Voort Maarschalk, Herman Vromans.   

Abstract

PURPOSE: By pharmaceutical processes and in the presence of solid excipients physical-chemical changes are known to occur, leading to increased rate of chemical degradation. The purpose of this work was to determine the critical aspects in the stability of a steroid in the presence of a commonly used excipient, lactose.
METHODS: A steroid was either mixed or wet granulated with lactose with different particle size.
RESULTS: Small lactose particles lead to a higher degree of degradation. Degradation was enhanced under warm humid conditions although the presence of water alone could not account for this effect. Lactose-phosphate, a known intrinsic contaminant in lactose is demonstrated to enhance the degradation of the steroid. Stability was improved in high purity lactose and deteriorated upon extra addition of phosphates. Since the exposure to the contaminant is a function of the surface area of the lactose, particle size differences of the excipient have a clear consequence. High shear granulated lactose granules exhibit a heterogeneous composition; large granules consist of small primary particles and vice versa. It is shown that the large granules, composed of the small primary lactose particles reveal the highest degree of degradation. Granule composition dictates the stability profile of the granules.
CONCLUSION: The lactose contaminant and granule composition dictates the stability profile of the granules and mixtures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670867     DOI: 10.1007/s11095-008-9687-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Effects of high-shear granulation on granulate homogeneity.

Authors:  H Vromans; H G Poels-Janssen; H Egermann
Journal:  Pharm Dev Technol       Date:  1999-08       Impact factor: 3.133

2.  Decomposition of p-aminosalicylic acid in the solid state.

Authors:  J T Cartensen; P Pothisiri
Journal:  J Pharm Sci       Date:  1975-01       Impact factor: 3.534

3.  Decomposition of aspirin in the solid state.

Authors:  L J LEESON; A M MATTOCKS
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1958-05

4.  The effect of inert atmospheric packaging on oxidative degradation in formulated granules.

Authors:  Rajiv Mahajan; Allen Templeton; Amy Harman; Robert A Reed; Rey T Chern
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 5.  The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations.

Authors:  Matthew D Jones; Robert Price
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Granule breakage during drying processes.

Authors:  Florentine J S Nieuwmeyer; Kees van der Voort Maarschalk; Herman Vromans
Journal:  Int J Pharm       Date:  2006-08-22       Impact factor: 5.875

7.  The consequences of granulate heterogeneity towards breakage and attrition upon fluid-bed drying.

Authors:  Florentine Nieuwmeyer; Kees van der Voort Maarschalk; Herman Vromans
Journal:  Eur J Pharm Biopharm       Date:  2008-03-18       Impact factor: 5.571

8.  Evaluation of hydroperoxides in common pharmaceutical excipients.

Authors:  Walter R Wasylaschuk; Paul A Harmon; Gabriella Wagner; Amy B Harman; Allen C Templeton; Hui Xu; Robert A Reed
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

9.  Decomposition of aspirin in the solid state in the presence of limited amounts of moisture III: Effect of temperature and a possible mechanism.

Authors:  J T Carstensen; F Attarchi
Journal:  J Pharm Sci       Date:  1988-04       Impact factor: 3.534

10.  The crystal structure and mechanism of 1-L-myo-inositol- 1-phosphate synthase.

Authors:  Adam J Stein; James H Geiger
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

View more
  1 in total

Review 1.  Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.

Authors:  Yongmei Wu; Jaquan Levons; Ajit S Narang; Krishnaswamy Raghavan; Venkatramana M Rao
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.